Sunshine Act Meetings, 15234 [2020-05602]

Download as PDF 15234 Federal Register / Vol. 85, No. 52 / Tuesday, March 17, 2020 / Notices Commission’s rules and regulations in 10 CFR Chapter I, which are set forth in the license amendment. A notice of consideration of issuance of amendment to facility operating license or COL, as applicable, proposed no significant hazards consideration determination, and opportunity for a hearing in connection with these actions, was published in the Federal Register on December 17, 2019 (84 FR 68953). No comments were received during the 30-day comment period. The Commission has determined that these amendments satisfy the criteria for categorical exclusion in accordance with 10 CFR 51.22. Therefore, pursuant to 10 CFR 51.22(b), no environmental impact statement or environmental assessment need be prepared for these amendments. IV. Conclusion Using the reasons set forth in the combined safety evaluation, the staff granted the exemptions and issued the amendments that SNC requested on October 31, 2019. The exemptions and amendments were issued on March 6, 2020, as part of a combined package to SNC (ADAMS Accession No. ML20044C903). 10:00 a.m. Strategic Programmatic Overview of the Operating Reactors and New Reactors Business Lines (Public Meeting) (Contact: Luis Betancourt: 301–415–6146) This meeting will be webcast live at the Web address—https://www.nrc.gov/ . Week of April 6, 2020—Tentative There are no meetings scheduled for the week of April 6, 2020. Week of April 13, 2020—Tentative There are no meetings scheduled for the week of April 13, 2020. Week of April 20, 2020—Tentative There are no meetings scheduled for the week of April 20, 2020. The Meeting with the Advisory Committee on the Medical Uses of Isotopes scheduled for March 31, 2020, has been postponed. ADDITIONAL INFORMATION: CONTACT PERSON FOR MORE INFORMATION: Week of March 30, 2020—Tentative For more information or to verify the status of meetings, contact Denise McGovern at 301–415–0681 or via email at Denise.McGovern@nrc.gov. The schedule for Commission meetings is subject to change on short notice. The NRC Commission Meeting Schedule can be found on the internet at: https://www.nrc.gov/public-involve/ public-meetings/schedule.html. The NRC provides reasonable accommodation to individuals with disabilities where appropriate. If you need a reasonable accommodation to participate in these public meetings or need this meeting notice or the transcript or other information from the public meetings in another format (e.g., braille, large print), please notify Anne Silk, NRC Disability Program Specialist, at 301–287–0745, by videophone at 240–428–3217, or by email at Anne.Silk@nrc.gov. Determinations on requests for reasonable accommodation will be made on a case-by-case basis. Members of the public may request to receive this information electronically. If you would like to be added to the distribution, please contact the Nuclear Regulatory Commission, Office of the Secretary, Washington, DC 20555 (301– 415–1969), or by email at Tyesha.Bush@ nrc.gov. The NRC is holding the meetings under the authority of the Government in the Sunshine Act, 5 U.S.C. 552b. There are no meetings scheduled for the week of March 30, 2020. Dated at Rockville, Maryland, this 13th day of March 2020. Dated at Rockville, Maryland, this 11th day of March, 2020. For the Nuclear Regulatory Commission. Victor E. Hall, Chief, Vogtle Project Office, Office of Nuclear Reactor Regulation. [FR Doc. 2020–05386 Filed 3–16–20; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [NRC–2020–0001] Sunshine Act Meetings Weeks of March 16, 23, 30, April 6, 13, 20, 2020. PLACE: Commissioners’ Conference Room, 11555 Rockville Pike, Rockville, Maryland. STATUS: Public. TIME AND DATE: Week of March 16, 2020 khammond on DSKJM1Z7X2PROD with NOTICES Thursday, April 2, 2020 There are no meetings scheduled for the week of March 16, 2020. Week of March 23, 2020—Tentative There are no meetings scheduled for the week of March 23, 2020. VerDate Sep<11>2014 17:32 Mar 16, 2020 Jkt 250001 PO 00000 Frm 00126 Fmt 4703 Sfmt 4703 For the Nuclear Regulatory Commission. Denise L. McGovern, Policy Coordinator, Office of the Secretary. [FR Doc. 2020–05602 Filed 3–13–20; 11:15 am] BILLING CODE 7590–01–P SECURITIES AND EXCHANGE COMMISSION [Release No. 34–88359; File No. SR– CboeBYX–2020–008] Self-Regulatory Organizations; Cboe BYX Exchange, Inc.; Notice of Filing and Immediate Effectiveness of a Proposed Rule Change Relating To Amend the Fee Schedule March 11, 2020. Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (the ‘‘Act’’),1 and Rule 19b–4 thereunder,2 notice is hereby given that on March 2, 2020, Cboe BYX Exchange, Inc. (the ‘‘Exchange’’ or ‘‘BYX’’) filed with the Securities and Exchange Commission (the ‘‘Commission’’) the proposed rule change as described in Items I, II, and III below, which Items have been prepared by the Exchange. The Commission is publishing this notice to solicit comments on the proposed rule change from interested persons. I. Self-Regulatory Organization’s Statement of the Terms of Substance of the Proposed Rule Change Cboe BYX Exchange, Inc. (the ‘‘Exchange’’ or ‘‘BZX’’) is filing with the Securities and Exchange Commission (‘‘Commission’’) a proposed rule change to amend the fee schedule. The text of the proposed rule change is provided in Exhibit 5. The text of the proposed rule change is also available on the Exchange’s website (http://markets.cboe.com/us/ equities/regulation/rule_filings/byx/), at the Exchange’s Office of the Secretary, and at the Commission’s Public Reference Room. II. Self-Regulatory Organization’s Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change In its filing with the Commission, the Exchange included statements concerning the purpose of and basis for the proposed rule change and discussed any comments it received on the proposed rule change. The text of these statements may be examined at the places specified in Item IV below. The Exchange has prepared summaries, set forth in sections A, B, and C below, of 1 15 2 17 U.S.C. 78s(b)(1). CFR 240.19b–4. E:\FR\FM\17MRN1.SGM 17MRN1

Agencies

[Federal Register Volume 85, Number 52 (Tuesday, March 17, 2020)]
[Notices]
[Page 15234]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-05602]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2020-0001]


Sunshine Act Meetings

TIME AND DATE: Weeks of March 16, 23, 30, April 6, 13, 20, 2020.

PLACE: Commissioners' Conference Room, 11555 Rockville Pike, Rockville, 
Maryland.

STATUS: Public.

Week of March 16, 2020

    There are no meetings scheduled for the week of March 16, 2020.

Week of March 23, 2020--Tentative

    There are no meetings scheduled for the week of March 23, 2020.

Week of March 30, 2020--Tentative

    There are no meetings scheduled for the week of March 30, 2020.

Thursday, April 2, 2020

10:00 a.m. Strategic Programmatic Overview of the Operating Reactors 
and New Reactors Business Lines (Public Meeting) (Contact: Luis 
Betancourt: 301-415-6146)
    This meeting will be webcast live at the Web address--https://www.nrc.gov/.

Week of April 6, 2020--Tentative

    There are no meetings scheduled for the week of April 6, 2020.

Week of April 13, 2020--Tentative

    There are no meetings scheduled for the week of April 13, 2020.

Week of April 20, 2020--Tentative

    There are no meetings scheduled for the week of April 20, 2020.

ADDITIONAL INFORMATION: The Meeting with the Advisory Committee on the 
Medical Uses of Isotopes scheduled for March 31, 2020, has been 
postponed.

CONTACT PERSON FOR MORE INFORMATION: For more information or to verify 
the status of meetings, contact Denise McGovern at 301-415-0681 or via 
email at [email protected]. The schedule for Commission meetings 
is subject to change on short notice.
    The NRC Commission Meeting Schedule can be found on the internet 
at: https://www.nrc.gov/public-involve/public-meetings/schedule.html.
    The NRC provides reasonable accommodation to individuals with 
disabilities where appropriate. If you need a reasonable accommodation 
to participate in these public meetings or need this meeting notice or 
the transcript or other information from the public meetings in another 
format (e.g., braille, large print), please notify Anne Silk, NRC 
Disability Program Specialist, at 301-287-0745, by videophone at 240-
428-3217, or by email at [email protected]. Determinations on requests 
for reasonable accommodation will be made on a case-by-case basis.
    Members of the public may request to receive this information 
electronically. If you would like to be added to the distribution, 
please contact the Nuclear Regulatory Commission, Office of the 
Secretary, Washington, DC 20555 (301-415-1969), or by email at 
[email protected].
    The NRC is holding the meetings under the authority of the 
Government in the Sunshine Act, 5 U.S.C. 552b.

    Dated at Rockville, Maryland, this 13th day of March 2020.

    For the Nuclear Regulatory Commission.
Denise L. McGovern,
Policy Coordinator, Office of the Secretary.
[FR Doc. 2020-05602 Filed 3-13-20; 11:15 am]
BILLING CODE 7590-01-P